Automation In Biopharma Industry Market Growth Outlook Through 2024-2033

Overview and Scope
Automation in the biopharma industry refers to integrating advanced technologies and robotics into various stages of the biopharmaceutical manufacturing process. It includes using automated systems and equipment to carry out tasks traditionally performed by humans, intending to increase efficiency, accuracy, and productivity in producing biopharmaceutical products.

Sizing and Forecast
The automation in biopharma industry market size has grown strongly in recent years. It will grow from $1.94 billion in 2023 to $2.06 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%.  The  growth in the historic period can be attributed to increased complexity in biopharmaceutical processes, need for improved process efficiency, growth in biologics development and manufacturing, demand for quality assurance and control, pressure to reduce time-to-market

The automation in biopharma industry market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.  The growth in the forecast period can be attributed to enhanced data integrity and documentation, rise of personalized medicine, rise of modular and flexible bioprocessing facilities, evolution of automation platforms, rising demand for biosimilars, adoption of smart sensors and internet of things (iot). Major trends in the forecast period include advances in robotics and automation technologies, advancements in single-use technologies, integration of artificial intelligence in bioprocessing, advances in process analytical technologies (pat), collaboration between biopharma and technology companies, emphasis on sustainability in biopharma automation.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Segmentation & Regional Insights
The automation in biopharma industry market covered in this report is segmented –
1) By Technology: Automation Technology, Digitization Technology
2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase
3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

North America was the largest region in the automation in biopharma industry market in 2023. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

Major Driver Impacting Market Growth
The increasing adoption of robots in pharmaceutical manufacturing is expected to propel the growth of automation in biopharma industry market. Robots in pharmaceutical manufacturing refer to advanced automated systems and machines that perform various tasks in producing and packaging pharmaceutical products. Robots are often used in multiple applications in pharmaceutical manufacturing, such as secondary packaging, intralogistics, laboratory automation, pick and place, automation of pharmacy processes, and personalized medicine, resulting in greater productivity, enhanced precision, reduced risk of contamination, and improved worker safety. For instance, in December 2021, according to the Association for Advancing Automation (A3), a US-based industry association promoting and advancing automation technologies, the North American robotics market achieved remarkable growth, with 29,000 units ordered valued at $1.48 billion in Q3 2021, with an impressive 37% increase in units sold. Moreover, the application of robotics in the life sciences, pharmaceutical, and biomedical sectors saw a substantial 36% increase in the first nine months of 2021. Therefore, the increasing adoption of robots in pharmaceutical manufacturing will drive the growth of automation in biopharma industry market.

Key Industry Players
Major companies operating in the automation in biopharma industry  market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

The automation in biopharma industry market report table of contents includes:
1. Executive Summary
2. Automation In Biopharma Industry Market Characteristics
3. Automation In Biopharma Industry Market Trends And Strategies
4. Automation In Biopharma Industry Market - Macro Economic Scenario
5. Global Automation In Biopharma Industry Market Size and Growth
…………
32. Global Automation In Biopharma Industry Market Competitive Benchmarking
33. Global Automation In Biopharma Industry Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Automation In Biopharma Industry Market
35. Automation In Biopharma Industry Market Future Outlook and Potential Analysis
36. Appendix